Skip to main content

This is out Privacy Policy

Privacy Policy

TrialWire™ Platform — HCP Privacy and Compliance Policy
Effective Date: January 2025

Purpose

This Privacy and Compliance Policy outlines the responsibilities of Healthcare Professionals (HCPs) using the TrialWire™ Platform to ensure compliance with the Health Insurance Portability and Accountability Act (HIPAA), applicable national and international regulations, and TrialWire’s own patient privacy standards.

Use of the TrialWire™ Platform by HCPs confirms acceptance of this policy and agreement to uphold all regulatory and ethical obligations relating to patient data and clinical trial recruitment activities.

1. HIPAA and Privacy Law Compliance

All HCPs must ensure full compliance with HIPAA in the U.S., as well as any other applicable national or regional privacy regulations (e.g., Australian Privacy Principles, GDPR for EU-based users, etc.).

  • HCPs must only upload, submit, or access de-identified or appropriately consented patient information via the TrialWire™ Platform. Please note: Patient referrals on the Platform have consented to sharing their information with the relevant Site team and have asked to be contacted regarding a study.

  • Protected Health Information (PHI) must not be shared unless expressly permitted under applicable regulations and with appropriate patient consent.

  • Any patient data handled via the Platform must be treated as confidential and accessed only for legitimate recruitment or clinical purposes.

2. Use of Patient Information

HCPs agree to:

  • Access and use the TrialWire™ Platform only for the purpose of matching eligible patients to clinical trials listed on the Platform.

  • Maintain patient confidentiality and not disclose patient details to third parties outside the trial sponsor, CRO, or authorized Site team, unless required by law.

  • Not use the Platform for any marketing, commercial promotion, or non-clinical purposes.

3. Data Security

HCPs must ensure:

  • They use secure devices and networks when accessing the Platform.

  • Login credentials are kept private and are not shared with any unauthorized parties.

  • Patient data accessed through the Platform is not stored, printed, or shared outside secure, approved systems.

TrialWire uses encryption and other best-practice data protection technologies to safeguard all data stored or transmitted via the Platform.

4. Informed Consent

HCPs are responsible for ensuring:

  • That any patient information shared with TrialWire is provided with documented informed consent, where applicable.

  • Patients are aware of how their information will be used and what trial opportunities may be presented to them.

5. Breach Reporting

HCPs must report any suspected or confirmed data breach or unauthorized access related to TrialWire™ within 24 hours to the designated TrialWire Privacy Officer at: [email protected]

6. Regulatory Oversight and Audit

TrialWire™ reserves the right to audit HCP activity on the Platform to ensure compliance with this policy and applicable laws. Non-compliance may result in immediate suspension of access privileges and notification to relevant regulatory bodies.

7. Acknowledgement

By accessing the TrialWire™ Platform, HCPs acknowledge:

  • Their obligation to comply with HIPAA, patient privacy laws, and this policy.

  • That misuse or unauthorized disclosure of patient data may lead to penalties under law and loss of platform access.

Contact

For any questions about this Privacy Policy, please contact:
📧 [email protected]
🌐 www.trialwire.com/privacy-policy

If you have any questions, concerns, or requests regarding this Privacy Policy or your personal information, please contact us at [email protected].

By using our services, you agree to the terms outlined in this Privacy Policy.